Is Telix Pharmaceuticals Limited (TLX) a Buy, Sell, or Hold?
NASDAQ : TLX
Telix Pharmaceuticals Limited — Analyst Ratings
$9.89 USD
-$0.17 (-1.69%)
- Volume
- 80.66K
- Average Volume
- 160.27K
- Market Capitalization
- $3.35B
- P/E Ratio
- -442.68
- Dividend Yield
- 0.00%
- Price Target
- $18.00
- Year High
- $14.27
- Year Low
- $6.28
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.43
Analyst Consensus Summary
Consensus Rating
Strong Sell
5 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-45.1%
vs Current Price
Price Target
$18.00
Average TargetPrice Target Range
Lowest Target
$18.00
-45.1% DOWNSIDE
Average Target
$18.00
Median Estimate
Highest Target
$18.00
-45.1% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 5
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 4 | 1 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| UBS | Laura Sutcliffe | $20 | $10.92 | 2025-09-23 08:36 AM | 83.2% |
| H.C. Wainwright | Robert Burns | $20 | $9.69 | 2025-09-10 08:22 AM | 106.4% |